Corynebacterium glutamicum for use in producing 2′-fucosyllactose

US10570399B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10570399-B2
Application numberUS-201715574028-A
CountryUS
Kind codeB2
Filing dateApr 24, 2017
Priority dateApr 25, 2016
Publication dateFeb 25, 2020
Grant dateFeb 25, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are a recombinant Corynebacterium glutamicum ( C. glutamicum ) for producing fucosyllactose which is transformed to express α-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (Gmd), GDP-L-fucose synthase (WcaG) and lactose permease (LacY), wherein the Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase, and a method for producing fucosyllactose using the same. According to the recombinant Corynebacterium glutamicum and the method for producing fucosyllactose according to the present invention, with use of a GRAS Corynebacterium glutamicum strain, which is safer than conventional Escherichia coli , 2′-fucosyllactose can be produced at a high concentration while overcoming drawbacks of conventional methods associated with industrial inapplicability resulting from low production concentrations.

First claim

Opening claim text (preview).

The invention claimed is: 1. A recombinant Corynebacterium glutamicum transformed to express α-1,2-fucosyltransferase, transformed to express GDP-D-mannose-4,6-dehydratase, transformed to express GDP-L-fucose synthase, and transformed to express lactose permease, wherein the recombinant Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase, and wherein the α-1,2-fucosyltransferase is encoded by fucT2 genes consisting of the nucleic acid sequence of SEQ ID NO: 6.

Assignees

Inventors

Classifications

  • Phosphomannomutase (5.4.2.8) · CPC title

  • GDP-mannose 4,6-dehydratase (4.2.1.47), i.e. GMD · CPC title

  • Mannose-1-phosphate guanylyltransferase (2.7.7.13) · CPC title

  • Phosphotransferases with an alcohol group as acceptor (2.7.1) · CPC title

  • Galactoside 2-alpha-L-fucosyltransferase (2.4.1.69) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10570399B2 cover?
Disclosed are a recombinant Corynebacterium glutamicum ( C. glutamicum ) for producing fucosyllactose which is transformed to express α-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (Gmd), GDP-L-fucose synthase (WcaG) and lactose permease (LacY), wherein the Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase, and a method for producing …
Who is the assignee on this patent?
Seoul Nat Univ R&Db Foundation, Ap Tech Corp
What technology area does this patent fall under?
Primary CPC classification C12N15/77. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).